Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: AVAI )

0.6100 -0.0200 (-3.17%)
Streaming Delayed Price Updated: 3:46 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 174,577
Open 0.6300
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.6300
Today's Range 0.6000 - 0.7700
52wk Range 0.2100 - 1.980
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Avant Technologies JV Partner to Speak at AI Revolution in Healthcare Summit in Dubai
Via ACCESS Newswire
Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:BBAI),(NASDAQ:TALK),(NASDAQ:SOUN) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety

Performance

YTD
+25.77%
+25.77%
1 Month
+31.18%
+31.18%
3 Month
+13.03%
+13.03%
6 Month
-17.57%
-17.57%
1 Year
+19.61%
+19.61%

More News

Read More
Avant Technologies and Ainnova Advance Toward FDA Clinical Trial with Selection of Top CRO
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
From FN Media Group LLC
Via GlobeNewswire
Avant Technologies and Ainnova Advance Toward FDA Clinical Trial with Selection of Top CRO
Via ACCESS Newswire
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
How HealthCare Industry is Leveraging Artificial Intelligence to Revolutionize Diagnostics and Early Disease Detection
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
The Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Avant Technologies and Ainnova Secure Advanced AI Algorithms for Early Detection of Four Additional Diseases in the U.S.
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
Via FinancialNewsMedia
Topics Artificial Intelligence Climate Change
Exposures Artificial Intelligence Climate
The Intersection of AI, Medicine, and Stocks: A New Era of Opportunities
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
From FN Media Group LLC
Via GlobeNewswire
Artificial Intelligence (AI) Redefining Medical Diagnostics Industry That’s Expected to be a $7.2 Billion Market by 2029
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Avant Technologies’ Partner, Ainnova, Signs Pilot Program with Roche to Combat Diabetic Retinopathy
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential
Via FinancialNewsMedia
Topics Artificial Intelligence Fraud
Exposures Artificial Intelligence Legal
Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential
From FN Media Group LLC
Via GlobeNewswire
Avant Technologies and Ainnova Advancing Proprietary Retinal Camera to Market with Vision AI Software
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
How AI is Shaping the Future of Healthcare: Key Advances in Diagnostics and Precision Medicine
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Global Artificial Intelligence (AI) Influence on Healthcare Market Expected to Reach $148 Billion By 2029
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Global Artificial Intelligence (AI) Influence on Healthcare Market Expected to Reach $148 Billion By 2029
From FN Media Group LLC
Via GlobeNewswire
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.